Clinical trial
Harmonizing Optimal Strategy for Treatment of Coronary Atherosclerotic Lesions - Registry-based Study on the Effect and Safety of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerotic Lesions: HOST-Onyx Registry
NCT03151018 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Harmonizing Optimal Strategy for Treatment of Coronary Atherosclerotic Lesions - Registry-based Study on the Effect and Safety of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerotic Lesions: HOST-Onyx Registry
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2015
- Completion date
- May 31, 2021
- Enrollment
- 4,000 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.